CFI and age-related macular degeneration: For clinical development of FI-targeted therapies to reach global populations, there needs to be more sequencing studies conducted on AMD populations from diverse ethnicities and geographies, in order to identify population-specific CFI rare variants that can be functionally characterised for their effect on the FI protein, and CS pathway.